Multidrug-resistant tuberculosis at an HIV testing center in Haiti

AIDS

Volumn 20, Issue 3, 2006, Pages 415-418

  Joseph, Patrice ^a   Severe, Patrice ^a   Ferdinand, Severine ^b   Kye, Seng Goh ^b   Sola, Christophe ^b   Haas, David W ^c   Johnson, Warren D ^d   Rastogi, Nalin ^b   Pape, Jean W ^a,d   Fitzgerald, Daniel W ^d,e  

^a Centers Institute of Infectious Diseases and Reproductive Health   (Haïti)

^b Institut Pasteur de Guadeloupe   (Guadeloupe)

^c VANDERBILT UNIVERSITY   (United States)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

^e Department of Molecular Biology and Genetics   (United States)

Author keywords

Haiti; HIV; Multidrug resistant tuberculosis

Indexed keywords

ETHAMBUTOL; ISONIAZID; RIFAMPICIN; STREPTOMYCIN;

ADULT; ARTICLE; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; CONTROLLED STUDY; COUGHING; DRUG SENSITIVITY; EPIDEMIOLOGICAL DATA; FEMALE; HAITI; HEALTH CENTER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION CONTROL; INFECTION PREVENTION; INFECTION RATE; INFECTION RISK; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; PREVALENCE; PRIORITY JOURNAL; RECURRENT INFECTION; SPUTUM CULTURE; SUPERINFECTION; VIRUS TRANSMISSION;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; CROSS-SECTIONAL STUDIES; FEMALE; HAITI; HUMANS; MALE; PREVALENCE; RECURRENCE; RISK FACTORS; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY;

EID: 33645022400     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.aids.0000206505.09159.9a     Document Type: Article

References (29)

1. Deschamps MM, Fitzgerald DW, Pape JW, Johnson WD Jr. HIV infection in Haiti: natural history and disease progression. AIDS 2000; 14:2515-2521.
2. Grant AD, Djomand G, De Cock KM. Natural history and spectrum of disease in adults with HIV/AIDS in Africa. AIDS 1997; 11 (suppl B):S43-S54.
3. Espinal MA, Reingold AL, Koenig E, Lavandera M, Sanchez S. Screening for active tuberculosis in HIV testing centre. Lancet 1995; 345:890-893.
4. Burgess AL, Fitzgerald DW, Severe P, Joseph P, Noel E, Rastogi N, et al. Integration of tuberculosis screening at an HIV voluntary counselling and testing centre in Haiti. AIDS 2001; 15:1875-1879.
5. Godfrey Fausett P, Maher D, Mukadi Y, Nunn P, Perriens J, Raviglione M. How human immunodeficiency virus voluntary testing can contribute to tuberculosis control. Bull World Health Org 2002; 80:939-945.
6. Frieden TR, Sterling T, Pablos-Mendez A, Kilburn JO, Cauthen GM, Dooley SW. The emergence of drug-resistant tuberculosis in New York City. N Engl J Med 1993; 328:521-526.
7. Ritacco V, Di Lonardo M, Reniero A, Ambroggi M, Barrera L, Dambrosi A, et al. Nosocomial spread of human immunodeficiency virus-related multidrug-resistant tuberculosis in Buenos Aires. J Infect Dis 1997; 176:637-642.
8. Moro ML, Gori A, Errante I, Infuso A, Franzetti F, Sodano L, et al. An outbreak of multidrug-resistant tuberculosis involving HIV-infected patients of two hospitals in Milan, Italy. Italian Multidrug-Resistant Tuberculosis Outbreak Study Group. AIDS 1998; 12:1095-1102.
9. Munsiff SS, Bassoff T, Nivin B, Li J, Sharma A, Bifani P, et al. Molecular epidemiology of multidrug-resistant tuberculosis, New York City, 1995-1997. Emerg Infect Dis 2002; 8:1230-1238.
10. Campos PE, Suarez PG, Sanchez J, Zavala D, Arevalo J, Ticona E, et al. Multidrug-resistant Mycobacterium tuberculosis in HIV-infected persons. Peru Emerg Infect Dis 2003; 9:1571-1578.
11. World Health Organization. The Right to Know. New Approaches to HIV Testing and Counseling. http://www.emro. who.int/ASD/backgrounddocuments/ egy0703/RighttoKnow. pdf [Accessed 12 July 2005].
12. Sweat M, Gregorich S, Sangiwa G, Furlonge C, Balmer D, Kamenga C, et al. Cost-effectiveness of voluntary HIV-1 counselling and testing in reducing sexual transmission of HIV-1 in Kenya and Tanzania. Lancet 2000; 356:113-121.
13. The Voluntary HIV-1 Counseling and Testing Efficacy Study Group. Efficacy of voluntary HIV-1 counselling and testing in individuals and couples in Kenya, Tanzania, and Trinidad: a randomised trial. Lancet 2000; 356:103-112.
14. Corbett EL, Watt CJ, Walker N, Maher D, Williams BG, Raviglione MC, et al. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med 2003; 163:1009-1021.
15. UNAIDS. Haiti: Epidemiological Fact Sheet. http://www.unaids.org [Accessed on January 2000].
16. Peck R, Fitzgerald DW, Liautaud B, Deschamps MM, Verdier MM, Beaulieu ME, et al. The feasibility, demand, and effect of integrating primary care services with HIV voluntary counseling and testing (VCT): evaluation of a 15 year experience in Haiti, 1985 - 2000. J Acquir Immune Defic Syndr 2003; 33: 470-475.
17. Allan WG, Girling DJ, Fayers PM, Fox W. The symptoms of newly diagnosed pulmonary tuberculosis and patients' attitudes to the disease and its treatment in Hong Kong. Tubercle 1979; 60:211-223.
18. Teklu B. Symptoms of pulmonary tuberculosis in consecutive smear-positive cases treated in Ethiopia. Tuber Lung Dis 1993; 74:126-128.
19. American Thoracic Society, Centers for Disease Control, Infectious Disease Society of America. Treatment of tuberculosis. MMWR 2003; 52(RR11):1-72.
20. Blower SM, Chou T. Modeling the emergence of the 'hot zones': tuberculosis and the amplification dynamics of drug resistance. Nat Med 2004; 10:1111-1116.
21. Sonnenberg P, Murray J, Glynn JR, Shearer S, Kambashi B, Godfrey-Faussett P. HIV-1 and recurrence, relapse, and reinfection of tuberculosis after cure: a cohort study in South African mineworkers. Lancet 2001; 358:1687-1693.
22. De Kock KM, Soro B, Coulibaly IM, Lucas SB. Tuberculosis and HIV infection in sub-Saharan Africa. JAMA 1992; 268:1581-1587.
23. Advisory Committee for the Elimination of Tuberculosis (ACET). Tuberculosis and human immunodeficiency virus infection. MMWR 1998; 47(RR20):18-42.
24. Dye C, Scheele S, Dolin P, Pathania V, Raviglione MC. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA 1999; 282:677-686.
25. Mukherjee J, Rich M, Socci A, Joseph J, Virú F, Shin S, et al. Programmes and principles in treatment of multidrug-resistant tuberculosis. Lancet 2004; 363 (9407):474-481.
26. Scalcini M, Carre G, Jean-Baptiste M, Hershfield E, Parker S, Wolfe J, et al. Antituberculous drug resistance in central Haiti. Am Rev Respir Dis 1990; 142:508-511.
27. Pitchenik AE, Russell BW, Cleary T, Pejovic I, Cole C, Snider DE. The prevalence of antituberculous drug resistance among Haitians. N Engl J Med 1982; 307:162-165.
28. Malone JL, Paparello SF, Malone JD, Hill HE, Conrad KA, Myers JW, et al. Drug susceptibility of Mycobacterium tuberculosis isolates from recent Haitian migrants: correlation with clinical response. Clin Infect Dis 1994; 19:938-940.
29. Harries AD, Maher D, Nunn P. Practical and affordable measures for the protection of health care workers from tuberculosis in low-income countries. Bull World Health Org 1997; 75:477-489.